B. Braun Cefazolin Duplex Container for Injection USP and Dextrose Injection USP (24/Case)

The B. Braun Duplex container is engineered as a ready-to-use IV system to simplify preparation, minimize waste, and enhance safety at the point of care. It streamlines the administration process by:

• Eliminating Manual Compounding: The two-compartment design stores the pre-measured drug (Cefazolin) and diluent (Dextrose) separately, removing the need for measuring and mixing from external vials.
• Easy Activation: To prepare the solution, you only need to fold and squeeze the flexible bag to combine the contents right at the patient’s bedside.
• Integrated Safety: The system prevents the administration of the diluent alone, ensuring the medication component is always delivered, which reduces the risk of medication errors.
• Convenient Storage: The containers have a long total shelf life of 19 months and can be stored at room temperature, eliminating the need for thawing or specialized refrigeration.

Yes, the B. Braun Cefazolin Duplex Container incorporates several robust safety features designed to protect the patient, safeguard medication integrity, and ensure efficient clinical workflow.

Key safety assurances include:

• Integrated Error Prevention: The two-compartment design prevents the accidental delivery of diluent without the active drug (Cefazolin), protecting medication efficacy and reducing critical medication errors.
• Material Safety: The container is constructed without latex, PVC, or DEHP, minimizing potential allergic reactions and ensuring safer disposal.
• Contamination Protection: The system is a closed system that maintains sterility and protects the drug’s potency until the moment of administration.
• Streamlined Compliance: This container meets guidelines set by the Joint Commission and USP 797.
• Automated Accuracy: Each unit features barcode references for the final admixture, supporting compatibility with automated dispensing systems and ensuring correct drug identification for charting.

The B. Braun Cefazolin Duplex Container features a closed system that effectively prevents contamination and helps to protect the potency of the medication. This design ensures a safe and sterile administration process.

Each case of B. Braun Cefazolin Duplex Containers contains 24 units.

The B. Braun Cefazolin Duplex Container has a shelf life of 19 months.

Yes, the B. Braun Cefazolin Duplex Container can be used with automated dispensing systems and allows for automated charting via barcoding.

Yes, the B. Braun Cefazolin Duplex Container is designed with rigorous safety and compliance in mind, ensuring patient protection and medication integrity.

Key safety and compliance features include:

• Regulatory Compliance: The container meets both Joint Commission and USP 797 guidelines for sterile pharmaceutical compounding and delivery.
• Enhanced Material Safety: It is manufactured without latex, PVC, or DEHP. This eliminates common allergens and ensures safer disposal by preventing dioxin release.
• Closed System Integrity: The design utilizes a closed system to protect the drug’s potency by preventing external contamination until administration.
• Medication Efficacy: The specialized two-compartment system prevents the diluent (Dextrose) from being delivered without the medication (Cefazolin), which helps reduce medication errors.

The B. Braun Cefazolin Duplex Container is a ready-to-use IV system designed for simple, immediate activation right at the patient’s bedside, eliminating the need for external vials or complex reconstitution procedures.

To activate the container and mix the medication:

• Simply fold and squeeze the flexible bag.

This action breaks the internal seal, instantly mixing the pre-measured Cefazolin drug and the Dextrose diluent. This closed system enhances safety by protecting the medication’s potency and ensuring the diluent cannot be administered without the drug component.

The B. Braun Cefazolin Duplex Container is available in 1-gram and 2-gram sizes.

The B. Braun Duplex container is engineered as a closed, two-compartment flexible IV system to maximize the stability and efficacy of the Cefazolin drug component right up until administration.

Key features that ensure drug integrity and potency include:

• Separate Storage: The pre-measured drug and diluent doses are stored separately, eliminating stability concerns that arise from early mixture over the long 19-month shelf life.
• Closed System Integrity: The sealed design prevents external contamination and preserves medication potency, meeting high standards such as USP 797.
• Integrated Safety Mechanism: The container design prevents the delivery of the diluent (Dextrose) without the medication, protecting efficacy and reducing the risk of administration errors.
• Convenient Storage: The container maintains its full shelf life while stored at room temperature, removing the need for freezing or thawing.